Beth Rogozinski

Beth Rogozinski is the Chief Executive Officer at Oncoustics, an AI diagnostics company focused on low-cost, non-invasive disease detection. Previously, Beth served as Chief Product Officer at Pear Therapeutics, where they led the development of the first prescription digital therapeutic cleared by the FDA. A serial entrepreneur and technology strategist, Beth has produced over 30 games and apps while holding various advisory and board positions across multiple organizations. Currently, they are active as an advisor for Neolth Inc. and Koa Health, among other roles in the digital health and innovation sectors.